Publications

(2022). Some considerations on target estimands for health technology assessment. Statistics in Medicine, 41(28).
(2022). Two-stage matching-adjusted indirect comparison. BMC Medical Research Methodology, 22(1).
(2022). Parametric G-computation for compatible indirect treatment comparisons with limited individual patient data. Research Synthesis Methods, 13(6).
(2022). Population-adjusted indirect treatment comparisons with limited access to patient-level data. Doctoral dissertation, UCL (University College London)).
(2021). Comparison of Parametric Survival Extrapolation Approaches Incorporating General Population Mortality for Adequate Health Technology Assessment of New Oncology Drugs. Value In Health, 24(9).
(2021). Methods for population adjustment with limited access to individual patient data - A review and simulation study. Research Synthesis Methods, 12(6).
(2021). Assessing the Impact of Modeling Non-Disease-Related Mortality on Long-Term Survivorship Rates in Previously Untreated Advanced Melanoma - A Case Study from CheckMate 067. In Value in Health, 24(S55).
(2020). Estimating long-term survivorship in patients with advanced melanoma treated with immune-checkpoint inhibitors - Analyses from the phase III CheckMate 067 trial. In Annals of Oncology, 31(S747).